Author(s):
Mahendra Prajapati, Rohitas Deshmukh, Ranjit Kumar Harwansh
Email(s):
mahendraprajapati530@gmail.com , rahi18rahi@gmail.com , harwanshranjeet@gmail.com
DOI:
10.52711/0974-360X.2025.00394 
Address:
Mahendra Prajapati, Rohitas Deshmukh*, Ranjit Kumar Harwansh
Institute of Pharmaceutical Research, GLA University, Mathura, 281406, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 6,
Year - 2025
ABSTRACT:
Colon cancer is the third most common cancer and has killed nearly 0.9 million people. The incidence and mortality rate of colorectal cancer increased day by day. Amygdalin act as an anticancer, anti-inflammatory, anti-atherosclerosis, anti-asthmatic, and immunosuppression. The goal of our research is to develop amygdalin-loaded nanosponges to sustainably deliver the drug to the colon region. Ultrasonication-assisted solvent evaporation method was employed to formulate AMY-loaded nanosponges using different concentrations of ERS-100 and PVA. Central composite face-centred design (CCFD) was implemented for statistical analysis and optimization and subsequent characterization, including DLS, ATR-FTIR, DSC, XRD, SEM, in vitro drug release, and MTT assay. The optimized formulation had a particle size of 154.4±11.46, a %EE of 72.96±1.06%, a %CDR24h of 83.191±0.93%, zeta potential of -5.045±2.45, and PDI value of 0.783±0.245. SEM analysis confirmed the porous and spherical nature of the nanosponges. ATR-FTIR, DSC, and XRD showed the polymer compatibility, entrapment of the drug in ERS-100 core, non-crystalline structure of amygdalin in nanosponges. Cytotoxicity study showed that pure amygdalin significantly decreased the cell viability of HT-29 colon cancer cell line. This study proved that AMY-loaded NS may be an effective delivery system for the effective treatment of colon cancer.
Cite this article:
Mahendra Prajapati, Rohitas Deshmukh, Ranjit Kumar Harwansh. Implementation of Central Composite Face-Centered Design (CCFD) For the Development and Optimization of Nanosponge Formulations of Amygdalin for the Treatment of Colon Cancer via In Vitro Assessment. Research Journal of Pharmacy and Technology. 2025;18(6):2746-5. doi: 10.52711/0974-360X.2025.00394
Cite(Electronic):
Mahendra Prajapati, Rohitas Deshmukh, Ranjit Kumar Harwansh. Implementation of Central Composite Face-Centered Design (CCFD) For the Development and Optimization of Nanosponge Formulations of Amygdalin for the Treatment of Colon Cancer via In Vitro Assessment. Research Journal of Pharmacy and Technology. 2025;18(6):2746-5. doi: 10.52711/0974-360X.2025.00394 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-6-47
REFERENCES:
1. El-Houssiny AS, Soliman AAF, Abdel-Nour KN. Assessment of the cytotoxic effect of carboxymethyl chitosan-loaded amygdalin nanoparticles against human normal and cancer cell lines. Discover Nano. 2024; 19(1): 62.
2. Deshmukh R, Prajapati M, Harwansh RK. A review on emerging targeted therapies for the management of metastatic colorectal cancers. Medical Oncology. 2023; 40(6): 159.
3. Deshmukh R, Kumari S, Harwansh RK. Inflammatory bowel disease: A snapshot of current knowledge. Research Journal of Pharmacy and Technology. 2020; 13(2): 956-62.
4. Deshmukh R, Prajapati M, Harwansh KR. Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches. Current Pharmaceutical Biotechnology. 2024; 25(5): 599-622.
5. Shi J, Chen Q, Xu M, Xia Q, Zheng T, Teng J, et al. Recent updates and future perspectives about amygdalin as a potential anticancer agent: A review. Cancer medicine. 2019; 8(6): 3004-11.
6. Jaszczak-Wilke E, Polkowska Ż, Koprowski M, Owsianik K, Mitchell AE, Bałczewski P. Amygdalin: Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds. Molecules (Basel, Switzerland). 2021; 26(8).
7. Spanoudaki M, Stoumpou S, Papadopoulou SK, Karafyllaki D, Solovos E, Papadopoulos K, et al. Amygdalin as a Promising Anticancer Agent: Molecular Mechanisms and Future Perspectives for the Development of New Nanoformulations for Its Delivery. 2023; 24(18): 14270.
8. Zhou J, Hou J, Rao J, Zhou C, Liu Y, Gao W. Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin. International Journal of Nanomedicine. 2020; 15: 4639-57.
9. Askar MA, El-Sayyad GS, Guida MS, Khalifa E, Shabana ES, Abdelrahman IY. Amygdalin-folic acid-nanoparticles inhibit the proliferation of breast cancer and enhance the effect of radiotherapy through the modulation of tumor-promoting factors/ immunosuppressive modulators in vitro. BMC Complementary Medicine and Therapies. 2023; 23(1): 162.
10. Sohail R, Abbas SR. Evaluation of amygdalin-loaded alginate-chitosan nanoparticles as biocompatible drug delivery carriers for anticancerous efficacy. International Journal of Biological Macromolecules. 2020;153: 36-45.
11. El-Ela FIA, Gamal A, Elbanna HA, ElBanna AH, Salem HF, Tulbah AS. In Vitro and In Vivo Evaluation of the Effectiveness and Safety of Amygdalin as a Cancer Therapy. Pharmaceuticals (Basel, Switzerland). 2022;15(11).
12. Meenatchi V, Narayanan KB, Sood A, Han SS. Formation of amygdalin/β-cyclodextrin derivatives inclusion complexes for anticancer activity assessment in human cervical carcinoma HeLa cell line. International Journal of Pharmaceutics. 2024: 124293.
13. Sulutas RB, Cesur S, Seyhan SA, Alkaya DB, Sahin A, Ekren N, et al. Electrospun amygdalin and Inula helenium extract-loaded polylactic acid (PLA)/Polyvinylpyrrolidone (PVP) nanofibrous patches for colon cancer treatment: Fabrication, characterization and antitumour effect results. Journal of Drug Delivery Science and Technology. 2024; 99: 105940.
14. Seyhan SA, Alkaya DB, Cesur S, Sahin A. Investigation of the antitumor effect on breast cancer cells of the electrospun amygdalin-loaded poly(l-lactic acid)/poly(ethylene glycol) nanofibers. International Journal of Biological Macromolecules. 2023; 239: 124201.
15. Hakimi F, Sharifyrad M, Safari H, khanmohammadi A, Gohari S, Ramazani A. Amygdalin/chitosan-polyvinyl alcohol/cerium-tannic acid hydrogel as biodegradable long-time implant for cancer recurrence care applications: An in vitro study. Heliyon. 2023; 9(11): e21835.
16. Harsha G, Shaik NB, Lakshmi PK, Latha K. Formulation and evaluation of sertaconazole nitrate loaded nanosponges for topical application. Research Journal of Pharmacy and Technology. 2021; 14(2): 895-902.
17. Satpathy TK, Chaubey N, Brahma CK, Maheshwari M. Formulation and Evaluation of Lamotrigine Loaded Nanosponges. Research Journal of Pharmacy and Technology. 2022; 15(1): 229-35.
18. Upadhye SS, Balkundhi S, Ghorpade VS, Ambavade SD, Abhang SV, Mulla SI, et al. Nanosponges: An innovative approach for targeted drug delivery system. Research Journal of Pharmacy and Technology. 2021; 14(3): 1797-804.
19. Pandya KD, Shah NV, Gohil DY, Seth AK, Aundhia CJ, Patel SS. Development of risedronate sodium-loaded nanosponges by experimental design: Optimization and in vitro characterization. Indian Journal of Pharmaceutical Sciences. 2019; 81(2): 309-16.
20. Ahmed MM, Fatima F, Anwer MK, Ansari MJ, Das SS, Alshahrani SM. Development and characterization of ethyl cellulose nanosponges for sustained release of brigatinib for the Treatment of Non-small Cell Lung Cancer. 2020; 40(10): 823-32.
21. Hamza MY, Aziz ZRAE, Kassem MA, El-Nabarawi MA. Loxoprofen Nanosponges: Formulation, Characterization and Ex-Vivo Study. International Journal of Applied Pharmaceutics. 2022; 14(2): 233-41.
22. Khute S, Jangde RK. Optimization of Nasal Liposome Formulation of Venlafaxine Hydrochloride using a Box-Behnken Experimental Design. Current Therapeutic Research. 2023; 99: 100714.
23. Noothi S, Malothu N, Areti A, Desu PK, Kumar S. Implication Of Central Composite Design In The Development Of Simvastatin-Loaded Nanosponges. International Journal of Applied Pharmaceutics. 2023; 15(5): 227-36.
24. Jangde RK, Khan T, Bhardwaj H. Development and Characterization of Nanostructured Lipid Carrier for Topical delivery of Naringenin. Research Journal of Pharmacy and Technology. 2023; 16(5): 2572-6.
25. Deshmukh R, Harwansh RK, Paul SD, Shukla R. Controlled release of sulfasalazine loaded amidated pectin microparticles through Eudragit S 100 coated capsule for management of inflammatory bowel disease. Journal of Drug Delivery Science and Technology. 2020; 55: 101495.
26. Ahsan Hafiz M, Abbas N, Bukhari NI. Quality by design approach for formulation development and evaluation of carboplatin loaded ethylcellulose nanosponges. International Journal of Polymeric Materials and Polymeric Biomaterials. 2022; 71(13): 1012-24.
27. Jangde RK, Khute S. Design and development of ciprofloxacin lipid polymer hybrid nanoparticle by response surface methodology. Research Journal of Pharmacy and Technology. 2020; 13(7): 3249-56.
28. Anwer MK, Ahmed MM, Aldawsari MF, Iqbal M, Soliman GA, Aljuffali IA. Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box–Behnken Design, and Anti-Diarrheal Activity. 2023; 15(5): 1460.
29. Jangde R, Elhassan GO, Khute S, Singh D, Singh M, Sahu RK, et al. Hesperidin-Loaded Lipid Polymer Hybrid Nanoparticles for Topical Delivery of Bioactive Drugs. 2022; 15(2): 211.
30. Prabhu PP, Prathvi, Gujaran TV, Mehta CH, Suresh A, Koteshwara KB, et al. Development of lapatinib nanosponges for enhancing bioavailability. Journal of Drug Delivery Science and Technology. 2021; 65: 102684.
31. Bhardwaj H, Jangde RK. Development and characterization of ferulic acid-loaded chitosan nanoparticle embedded- hydrogel for diabetic wound delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2024; 201: 114371.
32. Ranjitha R, Elango K, Devi DR, Sahul HNU. Formulation and Evaluation of Lovastatin Loaded Nanosponges for the treatment of Hyperlipidemia. Research Journal of Pharmacy and Technology. 2021;14(11):5653-60.
33. Deshmukh R, Trivedi V. Methemoglobin exposure produces toxicological effects in macrophages due to multiple ROS spike induced apoptosis. Toxicology In vitro: an International Journal Published in Association with BIBRA. 2013; 27(1): 16-23.
34. Pawar P, Duduskar A, Waydande S. Design and Evaluation of Eudragit RS-100 Based Itraconazole Nanosuspension for Ophthalmic Application. Current Drug Research Reviews. 2021; 13(1): 36-48.
35. Mansur HS, Sadahira CM, Souza AN, Mansur AAP. FTIR spectroscopy characterization of poly (vinyl alcohol) hydrogel with different hydrolysis degree and chemically crosslinked with glutaraldehyde. Materials Science and Engineering: C. 2008; 28(4): 539-48.
36. Marian E, Duteanu N, Vicas L, Rusu G, Jurca T, Muresan M, et al. Synthesis, characterization of inclusion compounds of amygdalin with β-cyclodextrin and sod-like activity and cytotoxicity on hela tumor cells. Arabian Journal of Chemistry. 2020; 13(8): 6828-37.
37. Ya, Shah NV, Gohil D, Seth AK, Aundhia C, Patel SSL. Development of Risedronate Sodium-loaded Nanosponges by Experimental Design: Optimization and in vitro Characterization. Indian Journal of Pharmaceutical Sciences. 2019.
38. Kumar L, Kumar R, Hussain SB, Kumari S, Pal Y. Development and Characterization of Polymeric Microsponge as a New Vehicle to Deliver Urea Topically. Recent Patents on Nanotechnology. 2023; 17(2): 131-43.